We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+5.87%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$833M
AUM Growth
+$240M
Cap. Flow
+$158M
Cap. Flow %
18.98%
Top 10 Hldgs %
35.14%
Holding
103
New
14
Increased
42
Reduced
34
Closed
7

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$19.1M
2
UNH icon
UnitedHealth
UNH
+$11.9M
3
COO icon
Cooper Companies
COO
+$7.39M
4
ESRX
Express Scripts Holding Company
ESRX
+$6.9M
5
MDT icon
Medtronic
MDT
+$6.56M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$4.81M
2
OCR
OMNICARE INC
OCR
+$3.85M
3
GILD icon
Gilead Sciences
GILD
+$3.17M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$3.01M
5
MCK icon
McKesson
MCK
+$3.01M

Sector Composition

Rank Sector Weight
1 Healthcare 76.95%
2 Financials 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EIGR
101
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-267
Closed -$2.27M
OCR
102
DELISTED
OMNICARE INC
OCR
– –
-50,000
Closed -$3.85M
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Rhenman & Partners Asset Management held 103 positions worth $833M, up 40% from $593M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rhenman & Partners Asset Management deployed $158M of net new capital in Q2 2015, opening 14 new positions and adding to 42 existing holdings. Its largest new stake was Johnson & Johnson: 191,000 shares worth $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 84% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Amgen, an estimated $4.81M trimmed.

  • Rhenman & Partners Asset Management's largest Q2 2015 buy was Johnson & Johnson: 191,000 shares worth $18.6M.
  • Rhenman & Partners Asset Management added most to UnitedHealth in Q2 2015, an estimated $11.9M increase.
  • Rhenman & Partners Asset Management's biggest Q2 2015 reduction was Amgen, cutting an estimated $4.81M.
  • Rhenman & Partners Asset Management fully exited OMNICARE INC in Q2 2015, selling an estimated $3.85M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 35% of its $833M portfolio in Q2 2015.
  • Rhenman & Partners Asset Management opened 14 new positions and closed 7 in Q2 2015.
  • Rhenman & Partners Asset Management's portfolio value rose 40% quarter-over-quarter to $833M.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2015, filed 30 Jul 2015.